137 related articles for article (PubMed ID: 4813575)
1. Urinary carcinoembryonic-like antigen levels in patients with bladder carcinoma.
Guinan P; John T; Sadoughi N; Ablin RJ; Bush I
J Urol; 1974 Mar; 111(3):350-2. PubMed ID: 4813575
[No Abstract] [Full Text] [Related]
2. Carcinoembryonic antigen in the urine of patients with urothelial carcinoma.
Hall RR; Laurence DJ; Darcy D; Stevens U; James R; Roberts S; Munro Neville A
Br Med J; 1972 Sep; 3(5827):609-11. PubMed ID: 5071696
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.
Steffens J; Friedmann W; Lobeck H
Urol Res; 1985; 13(2):55-9. PubMed ID: 2409654
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.
el-Ahmady O; Halim AB; el-Din AG
Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen and bladder carcinoma.
Ionescu G; Romas NA; Ionascu L; Bennett S; Tannenbaum M; Veeneman RJ; Lattimer JK
J Urol; 1976 Jan; 115(1):46-8. PubMed ID: 1107601
[TBL] [Abstract][Full Text] [Related]
7. Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.
Piana P; Casetta G; Cavallini A; Piantino P; Tizzani A
Prog Clin Biol Res; 1991; 370():179-84. PubMed ID: 1924448
[No Abstract] [Full Text] [Related]
8. Carcinoembryonic antigen and urothelial carcinoma.
Hall RR; Laurence DJ; Neville AM; Wallace DM
Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
[No Abstract] [Full Text] [Related]
9. Carcinoembryonic-like antigen in the urine of patients with carcinoma of the bladder and normal controls.
Guinan P; Ablin RJ; Sadoughi N; Bush IM
J Surg Oncol; 1974; 6(2):127-31. PubMed ID: 4822898
[No Abstract] [Full Text] [Related]
10. [Immunohistochemical demonstration of tumor-associated antigens in urinary bladder carcinomas using mono- and polyclonal antisera].
Friedmann W; Steffens J; Lobeck H
Onkologie; 1985 Apr; 8(2):105-10. PubMed ID: 2582324
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate antigen 19-9 and carcinoembryonic antigen-producing transitional cell carcinoma of the ureter and bladder: a case report.
Sakai H; Toyofuku K; Yogi Y; Minami Y; Kanetake H; Saito Y
J Urol; 1993 Jul; 150(1):182-4. PubMed ID: 8510248
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of the bladder tumor marker "Tu-MARK-BTA"].
Yogi S; Ikeuchi T; Yoshikawa H; Hamashima T; Sasaki H; Morikawa F; Onodera Y; Matsumoto K; Kai Y
Hinyokika Kiyo; 1991 Apr; 37(4):335-9. PubMed ID: 1891992
[TBL] [Abstract][Full Text] [Related]
13. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
[TBL] [Abstract][Full Text] [Related]
14. A correlative cytohistologic study on the interrelationship between exfoliated urinary bladder carcinoma cell types and the staging and grading of these tumors.
Suprun H; Bitterman W
Acta Cytol; 1975; 19(3):265-73. PubMed ID: 1056680
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid factor: correlation with recurrence in transitional cell carcinoma of the bladder.
Gupta NP; Malaviya AN; Singh SM
J Urol; 1979 Apr; 121(4):417-8. PubMed ID: 439209
[TBL] [Abstract][Full Text] [Related]
16. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer.
D'Hallewin MA; Baert L
J Urol; 1996 Feb; 155(2):475-6. PubMed ID: 8558639
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen in patients with urologic cancers.
Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
[No Abstract] [Full Text] [Related]
18. The role of TGF-beta-1 protein and TGF-beta-R-1 receptor in immune escape mechanism in bladder cancer.
Helmy A; Hammam OA; El Lithy TR; El Deen Wishahi MM
MedGenMed; 2007 Nov; 9(4):34. PubMed ID: 18311384
[TBL] [Abstract][Full Text] [Related]
19. The value of CEA assay in tissue, serum and urine in patients with transitional cell carcinoma of the bladder.
Alampi G; Ronchi E; Galassi A; Soli M; Botteghi B; Bercovich E
Arch Anat Cytol Pathol; 1985; 33(4):193-6. PubMed ID: 3904640
[No Abstract] [Full Text] [Related]
20. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ
J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
